Haleon plc (HLN) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NYSE. Price $9.28 (-0.85%), Market cap $41.28B, P/E ratio 18.64, 52-week low–high $8.72 ~ $11.41.
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Pa
Financial statements, price targets, institutional (13F) holdings and related news for Haleon plc are updated in real time on BlackAll Trade.
Haleon plc trades at $9.28 (-0.85%). Real-time quotes and charts are available on BlackAll Trade.
Haleon plc has a market cap of about $41.28B. Its P/E ratio is 18.64.
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin